• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

Log in
  • Search
    • Search All SAGES Content
    • Search SAGES Guidelines
    • Search the Video Library
    • Search the Image Library
    • Search the Abstracts Archive
www.sages.org

SAGES

Reimagining surgical care for a healthier world

  • Home
    • Search
    • SAGES Home
    • SAGES Foundation Home
  • About
    • Awards
    • Who Is SAGES?
    • Leadership
    • Our Mission
    • Advocacy
    • Committees
      • SAGES Board of Governors
      • Officers and Representatives of the Society
      • Committee Chairs and Co-Chairs
      • Committee Rosters
      • SAGES Past Presidents
  • Meetings
    • SAGES NBT Innovation Weekend
    • SAGES Annual Meeting
      • 2026 Scientific Session Call for Abstracts
      • 2026 Emerging Technology Call for Abstracts
    • CME Claim Form
    • SAGES Past, Present, Future, and Related Meeting Information
    • SAGES Related Meetings & Events Calendar
  • Join SAGES!
    • Membership Application
    • Membership Benefits
    • Membership Types
      • Requirements and Applications for Active Membership in SAGES
      • Requirements and Applications for Affiliate Membership in SAGES
      • Requirements and Applications for Associate Active Membership in SAGES
      • Requirements and Applications for Candidate Membership in SAGES
      • Requirements and Applications for International Membership in SAGES
      • Requirements for Medical Student Membership
    • Member Spotlight
    • Give the Gift of SAGES Membership
  • Patients
    • Join the SAGES Patient Partner Network (PPN)
    • Patient Information Brochures
    • Healthy Sooner – Patient Information for Minimally Invasive Surgery
    • Choosing Wisely – An Initiative of the ABIM Foundation
    • All in the Recovery: Colorectal Cancer Alliance
    • Find A SAGES Surgeon
  • Publications
    • Sustainability in Surgical Practice
    • SAGES Stories Podcast
    • SAGES Clinical / Practice / Training Guidelines, Statements, and Standards of Practice
    • Patient Information Brochures
    • Patient Information From SAGES
    • TAVAC – Technology and Value Assessments
    • Surgical Endoscopy and Other Journal Information
    • SAGES Manuals
    • MesSAGES – The SAGES Newsletter
    • COVID-19 Archive
    • Troubleshooting Guides
  • Education
    • Wellness Resources – You Are Not Alone
    • Avoid Opiates After Surgery
    • SAGES Subscription Catalog
    • SAGES TV: Home of SAGES Surgical Videos
    • The SAGES Safe Cholecystectomy Program
    • Masters Program
    • Resident and Fellow Opportunities
      • SAGES Free Resident Webinar Series
      • Fluorescence-Guided Surgery Course for Fellows
      • Fellows’ Career Development Course
      • SAGES Robotics Residents and Fellows Courses
      • MIS Fellows Course
    • SAGES S.M.A.R.T. Enhanced Recovery Program
    • SAGES @ Cine-Med Products
      • SAGES Top 21 Minimally Invasive Procedures Every Practicing Surgeon Should Know
      • SAGES Pearls Step-by-Step
      • SAGES Flexible Endoscopy 101
    • SAGES OR SAFETY Video Activity
  • Opportunities
    • Fellowship Recognition Opportunities
    • SAGES Advanced Flexible Endoscopy Area of Concentrated Training (ACT) SEAL
    • Multi-Society Foregut Fellowship Certification
    • Research Opportunities
    • FLS
    • FES
    • FUSE
    • Jobs Board
    • SAGES Go Global: Global Affairs and Humanitarian Efforts
  • OWLS/FLS
You are here: Home / Abstracts / Perforated Giant Marginal Ulcer While on Chemotherapy: a case report

Perforated Giant Marginal Ulcer While on Chemotherapy: a case report

Connal Robertsn-More, MD, Christopher de Gara, MBBS, Aliyah Kanji, MD, Daniel W Birch, MD, MSc, Shazeer Karmali, MD, MPH. University of Alberta

Introduction: Obesity is a common problem worldwide with numerous associated comorbidities and is associated with an increased risk of developing some cancers. Despite bariatric surgery being associated with a risk reduction for cancer development, some will develop cancer after surgery and little is known about complications which might arise during multimodality cancer treatment.

Here we report the case of a 55 year-old female who developed an unusual giant marginal ulcer (MU) post Laparoscopic Roux-en-Y-Gastric Bypass (LRYGB) while receiving systemic chemotherapy for an early stage breast cancer.

Case Report: In summary, a 55 year-old female with a preoperative BMI of 40kg/m2 had an uncomplicated LRYGB one year prior to her presentation. She was a non-smoker, was abstinent of alcohol and did not use NSAIDs, steroids or other ulcerogenic medications. Eight months post procedure with a BMI of 29.1kg/m2 she was diagnosed and treated with BCS plus SLNB for a pT2N0M0 ER/PR +ve HER2 –ve breast cancer. One week following her third cycle of docetaxel and cyclophosphamide, she presented with two days of melena, small volume hematemesis and abdominal discomfort. The patient was resuscitated with PRBC, started on a PPI infusion and had free air ruled out on a CXR. Upper endoscopy was complete showing a giant MU at the gastrojejunal anastomosis, biopsies ruled out malignancy and H.pylori. Subsequent CT abdomen/pelvis identified contrast extravasation from the anastomosis confirming a free perforation. Broad spectrum antibiotics were started and a diagnostic laparoscopy complete. A graham patch repair utilizing omentum and abdominal washout were complete with placement of surgical drains. The patient was supported with parenteral nutrition while NPO. Diet was advanced after an upper GI series on post operative day 7 showed no ongoing leak. The patient was discharged on post operative day 13, recovered and although further chemotherapy was discontinued she completed whole breast radiotherapy.

Conclusion: To our knowledge this is the first reported case of a perforated giant MU after LRYGB for severe obesity in a patient on systemic chemotherapy with no other risk factors for MU development. Spontaneous small bowel perforation has been documented in patients on chemotherapy without prior abdominal surgery. What is unknown is whether after LRYGB patients are at increased risk of anastomotic or other complications while on chemotherapy and we encourage others to report cases to develop a body of literature on the subject.


Presented at the SAGES 2017 Annual Meeting in Houston, TX.

Abstract ID: 87995

Program Number: P593

Presentation Session: iPoster Session (Non CME)

Presentation Type: Poster

171

Share this:

  • Click to share on X (Opens in new window) X
  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on Pinterest (Opens in new window) Pinterest
  • Click to share on WhatsApp (Opens in new window) WhatsApp
  • Click to share on Reddit (Opens in new window) Reddit
  • Click to share on Pocket (Opens in new window) Pocket
  • Click to share on Mastodon (Opens in new window) Mastodon

Related



Hours & Info

11300 West Olympic Blvd, Suite 600
Los Angeles, CA 90064

1-310-437-0544

[email protected]

Monday – Friday
8am to 5pm Pacific Time

Find Us Around the Web!

  • Bluesky
  • X
  • Instagram
  • Facebook
  • YouTube

Copyright © 2025 · SAGES · All Rights Reserved

Important Links

Healthy Sooner: Patient Information

SAGES Guidelines, Statements, & Standards of Practice

SAGES Manuals